NewsCura

Metropolitan Bank & Trust Company

Disclaimer: The research and recommendation below were generated by Claude Fable. Please treat this as one input for your own research — not as the sole basis for any decision to buy or sell a stock.

Last checked
Price
66.5000
Trading status
Normal
Recommendation
Buy (income plus value; watch capital ratios and flat profit growth)Buy
Committee call
Hold
Indices
PSEi, MSCI

Analysis

MBT - Metropolitan Bank & Trust Company

One-line summary: well-capitalized, Ty family-controlled universal bank trading at a deep discount to book and earnings (P/E ~6.0x, P/B ~0.73x) with clean asset quality and a 7.5% yield, but profit growth has decelerated to low single digits and capital ratios are eroding from a still-comfortable base.

Snapshot

Reviewed July 19, 2026
Index membership PSEi, MSCI
Price at review P66.50
Recommendation Buy (income-plus-value pick; watch capital ratio erosion and slowing profit growth)
Market cap P299.1B (4.50B shares)
Trailing P/E ~5.97x (FY2025: 6.20x)
Forward P/E ~5.73x (analyst consensus estimate)
Dividend (2026 plan) P5.00/share total (P3.00 regular + P2.00 special), ~7.52% yield at 66.50
P/B ~0.73x
Capital (in place of D/E) CAR 14.9%, CET1 14.2% (Q1 2026), both well above BSP minimums of 10% / 6%

No material change since the July 12, 2026 review: price drifted up about 2% (65.15 to 66.50), Q1 2026 remains the latest reported quarter (Q2 2026 results are due August 4, 2026), and no new dividend has been declared since the March 2026 tranche. News in the interim was limited to immaterial items: a "Strongest Bank in the Philippines" award (July 14, 2026, the fourth straight year), a routine Terms and Conditions update tied to digital wallet tokenization (effective July 20, 2026), and the decommissioning of the Bills Payment feature on ATMs and WDMs (July 1, 2026). None of these touch the investment thesis. Analyst consensus remains a Buy with an average 12-month price target of P83.95 (about 26% upside).

Net interest income, fees, and earnings trend

Metrobank's core engine is net interest income (NII), which has compounded steadily: P75.2B (2021), P85.7B (2022), P105.2B (2023), P114.3B (2024), P124.7B (2025), up again to P128.7B on a trailing-twelve-month basis through Q1 2026. Net income followed a similar climb from P22.2B (2021) to P49.7B (2025), a more than doubling in four years, largely on the back of loan book growth, wider margins as PH interest rates stayed elevated, and rising fee/trust income (P19.2B in 2025, +6%).

The growth rate has clearly decelerated. EPS growth was 60% (2021), 48% (2022), 29% (2023), 14% (2024), and just 3.3% (2025, EPS P11.06 vs P10.71). Q1 2026 confirms the slowdown: net income of P12.6B was up only 2.86% year on year, even though gross loans grew 9.2% and NII grew 13.6% to P33.4B. The gap between double-digit balance-sheet growth and near-flat bottom-line growth suggests rising funding costs, higher provisioning, or opex are eating into the NII gains. One notable one-off worth flagging: FY2025's "record" P49.7B profit was helped by a 47.2% jump in trading and FX income (to P8.2B), a market-dependent line that will not repeat every year. Some press coverage (Manila Bulletin) cited 2025 net income as "17% growth from P42.2B in 2024," but that P42.2B figure actually matches the FY2023 net income (P42.238B) per stockanalysis.com's structured data, not FY2024 (P48.137B). This page uses the stockanalysis figures throughout, which are internally consistent with the EPS growth series and the Q1 2026 comparison base.

Asset quality, margins, and capital adequacy

Free cash flow is not a meaningful concept for a bank (deposit-taking and lending are the operating business, not investing activity to be netted against operations), so this section substitutes the metrics that actually describe a bank's health.

  • Asset quality: NPL ratio was 1.7% at end-2025 and 1.75% in Q1 2026, essentially flat and well below the industry average (3.2% end-2025, 3.44% as of February 2026). NPL coverage is strong at 137-141%, meaning reserves exceed the bad-loan balance by a wide margin. This is a genuinely clean loan book by PH banking-sector standards.
  • Net interest margin: improved 12 basis points year on year to 3.7% in Q1 2026, helped by the elevated rate environment. A material BSP rate-cutting cycle would compress this; it is the single biggest swing factor in the earnings model.
  • Loan growth: gross loans grew 9.2% year on year in Q1 2026 (corporate/commercial +8.6%, consumer +11.2%), continuing FY2025's pace (total loans +8.8%, consumer +13.9%). Consumer lending, the higher-margin segment, is growing fastest.
  • Capital adequacy: CAR and CET1 stood at 16.8% and 16.1% at end-2025, but fell to 14.9% and 14.2% in Q1 2026, a meaningful one-quarter drop. Both remain comfortably above BSP's 10% CAR / 6% CET1 minimums, but the decline (likely a combination of the March 2026 special dividend payout and fast risk-weighted-asset growth from the loan book) is worth tracking. A bank funding double-digit loan growth mostly from retained earnings will keep shedding capital ratio unless profit growth reaccelerates.
  • Deposits: total deposits of P2.63 trillion at end-Q1 2026, with CASA (current/savings, the cheap funding) at 59.2% of the total and growing 8.4% year on year, a healthy funding mix.

Dividend sustainability

Metrobank has held its total dividend flat at P5.00/share (P3.00 aggregate regular + P2.00 special) for three consecutive declaration years now: based on FY2023 earnings (paid 2024), FY2024 earnings (paid 2025), and FY2025 earnings (the March 2026 tranche of P3.50 = P1.50 regular + P2.00 special, with a further P1.50 regular tranche expected around September 2026, matching the prior two years' pattern). Meanwhile EPS grew from P9.39 (2023) to P10.71 (2024) to P11.06 (2025), so the implied payout ratio has quietly fallen from about 53% to about 45%. That is not dividend growth so much as management choosing to retain a larger share of a growing profit base, consistent with a bank that needs capital to fund loan growth and rebuild the capital ratios noted above. The dividend looks very safe (well covered, backed by a bank with 14%+ CET1 and sub-2% NPLs) but investors buying for dividend growth specifically should not assume the per-share amount rises just because earnings do.

ROE

ROE climbed from 6.77% (2021) to 10.15% (2022), 12.37% (2023), 12.90% (2024), then eased slightly to 12.22% (2025) and 12.81% on a trailing basis; Q1 2026 ROE was 12.32%, down from 12.85% a year earlier. ROE has plateaued in the 12-13% band for three years now rather than continuing to climb, tracking the same deceleration visible in the earnings growth numbers. ROA has similarly flattened around 1.3-1.5%. This is a mid-teens-ROE bank, not spectacular but solid, and it is not being artificially flattered by unusual leverage: capital ratios are well above regulatory minimums, the opposite of a thin-equity-base story.

Capital allocation

Capital is being split three ways: (1) fund double-digit loan growth (the fastest use of capital, consuming the CET1 decline seen in Q1 2026), (2) pay a flat P5.00/share total dividend that now consumes a shrinking share of profit, and (3) rebuild/maintain capital buffers. There are no meaningful buybacks and no major acquisitions in the recent record. Ownership is concentrated: GT Capital Holdings, the Ty family's conglomerate, holds roughly 39.8% after increasing its stake in September 2025 (from 37.3%), with additional Ty family and related-party holdings on top of that; public float is roughly 48%. Arthur V. Ty chairs the board and Fabian S. Dee is president. This is a controlled company; minority shareholders are along for the ride on capital allocation decisions, though the flat, well-covered dividend and conservative capital ratios suggest a shareholder-friendly, low-drama approach rather than a promotional one.

Verdict at P66.50 (July 19, 2026)

Buy, with eyes open. The valuation is genuinely cheap in absolute terms: P/E just under 6x, P/B at 0.73x (the market is pricing the bank below its own book value despite a low-double-digit ROE and clean loan book), and a 7.5% dividend yield that is well covered by earnings (45% payout ratio) and backed by a bank with strong reserves. NPL ratio, coverage, and CASA funding mix are all better than the PH banking-sector average, and capital ratios, while declining, remain comfortably above regulatory minimums. Analyst consensus (per stockanalysis.com) carries a Buy rating with a roughly 26% upside price target.

The catch, and the reason this is not a higher-conviction call, is the growth deceleration: net income growth fell from the 20-60% range in 2021-2023 to about 3% in FY2025 and Q1 2026, even as loans grew 9%+ and NII grew double digits. Something (funding costs, provisioning, opex) is eating the difference, and FY2025's headline "record" profit leaned partly on a one-off-ish 47% jump in trading/FX income that will not repeat every year. Combined with the one-quarter capital ratio drop (CAR from 16.8% to 14.9%, CET1 from 16.1% to 14.2%), the valuation discount may partly reflect the market correctly pricing a bank whose earnings momentum has stalled, not just a PH-market liquidity discount. This is a controlled company (Ty family via GT Capital, ~40%+ combined stake); minority shareholders have no real say in capital allocation, though the record so far has been conservative rather than value-destructive.

What would change the call:

  • Buy trigger (add on weakness): price falls further while NPL stays below 2% and CET1 stays above 12%, i.e., the discount widens without any fundamental deterioration; or net income growth reaccelerates back into high single/double digits for two consecutive quarters, confirming FY2025's slowdown was transitory.
  • Sell trigger: NPL ratio rises toward the industry average (above ~2.5%), CET1 falls below roughly 12% (still above the 6% minimum but signaling real capital stress from loan growth outrunning retained earnings), the dividend is cut, or net income growth stays near zero for three or more consecutive quarters (confirming margin compression from BSP rate cuts is not being offset by volume growth).

PSE bank stocks can re-rate slowly; this is a multi-year holding thesis, not a trade. No buy or sell trigger fired this week: NPL is still well under 2%, CET1 is still above 12%, and net income growth (weak as it is) has not gone to zero for three straight quarters. Analysis, not financial advice.

Committee review (July 19, 2026)

Five investor lenses judged this page's facts independently, each strictly inside its own framework.

Lens Signal Confidence Core argument
Ben Graham Bullish 78 At P/B ~0.73x and trailing P/E ~5.97x, MBT trades at a clear discount to both net asset value and earning power. Five straight years of rising net income (P22.2B to P49.7B, no deficit year) satisfies the earnings-stability test, and CAR 16.8%/CET1 16.1% at end-2025 (still 14.9%/14.2% after the Q1 2026 dip, well above the 10%/6% BSP minimums) shows senior claims are conservatively covered. Flip trigger: P/B rising to par (1.0x) removes the asset discount, or CAR/CET1 keep sliding toward the regulatory floor over another quarter or two.
Warren Buffett Neutral 55 The 59.2% CASA deposit base and 1.7% NPL ratio (versus a 3.2-3.44% industry average) show real underwriting discipline, and at 0.73x book with a 12-13% ROE this isn't an expensive bank, but owner earnings aren't compounding cleanly: FY2025's record profit leaned on a 47.2% jump in trading/FX income while core growth stalled (Q1 2026 net income up just 2.86% against 13.6% NII growth), and EPS growth has decayed from 60% to 3.3% over five years. Flip trigger: ROE breaking convincingly above 15% on core NII and fee income (not trading gains) for two straight quarters while capital ratios stabilize.
Michael Burry Bullish 58 At 0.73x book and under 6x trailing earnings, with NPLs at 1.7% versus a 3.2-3.44% industry average and CET1 still 14.2% after the drop, the balance sheet offers real margin of safety the market is mispricing mid-range in its 52-week band. But the "record" FY2025 profit leaned on a 47.2% jump in non-repeatable trading/FX income, and Q1 2026 net income grew just 2.86% even as NII grew 13.6% and loans grew 9.2%, meaning reported earnings power is softer than the headline multiple suggests. Flip trigger: Q2 2026 results (August 4, 2026) showing core net income reconverging with NII and loan growth and CAR/CET1 stabilizing; if the profit gap persists or capital keeps eroding, exit.
Nassim Taleb Bearish 68 A bank is inherently a leveraged, opaque bet on tail risk, and this one just showed the tell: CAR fell from 16.8% to 14.9% and CET1 from 16.1% to 14.2% in a single quarter, while loan growth (9.2%) outpaced earnings power (EPS growth collapsed from 60% in 2021 to 2.86% in Q1 2026). Cheap multiples and a 7.52% yield don't compensate for shrinking capital buffers and a margin dependent on elevated rates persisting; the GT Capital family's 39.8% stake is a mitigant, not a fix, for the structural fragility of the balance sheet. Flip trigger: CAR/CET1 rebuild back above 16% for two consecutive quarters with earnings growth resuming from core NII rather than trading gains.
Stanley Druckenmiller Neutral 62 There is no fresh catalyst: EPS growth has collapsed from 60% in 2021 to 3.3% in 2025 and just 2.86% in Q1 2026, FY2025's record profit leaned on non-repeatable trading/FX income, and the 3.7% NIM is a rate-cycle bet, not a trade thesis. CAR/CET1 dropping a full percentage-plus in a single quarter with no new dividend since March removes the other reason to hold, and the interim news (an award, a T&C update, an ATM feature retirement) is noise. Flip trigger: Q2 2026 results (August 4, 2026) showing NII/loan growth reaccelerating without relying on trading income, or a clear BSP rate signal.

Conferred call: Hold (2 bullish, 1 bearish, 2 neutral, no majority either way; unchanged from the July 12, 2026 committee run). This splits from the page's Buy recommendation: the committee sees the same cheap valuation and clean asset quality Graham and Burry like, but weighs the capital ratio erosion and the loan-growth-to-earnings decoupling as reasons to wait for the August 4 print rather than add now. Against the rulebook in [[stock-trading-strategy-and-rules]], there is still no live catalyst or confirmed setup (no breakout, no fresh dividend declaration, no earnings print since Q1), so this stays a value/income holding thesis rather than a rulebook-quality trade setup right now; it is also not a "cheap at the lows" trap since the price sits mid-range within the 52-week band (61.95-78.25), not at a low. Shared flip trigger: the Q2 2026 earnings release on August 4, 2026, is the one date multiple lenses (Burry, Druckenmiller) are watching to confirm whether the growth slowdown is transitory or structural.

Review history

Date Price Recommendation
July 10, 2026 65.45 Buy (income-plus-value pick; watch capital ratio erosion and slowing profit growth)
July 12, 2026 65.15 Buy (no change; committee conferred Hold, first committee run for this page)
July 19, 2026 66.50 Buy (no change; committee reconferred Hold, no new triggers fired, awaiting Q2 2026 print on August 4)

Sources